2008
DOI: 10.5144/0256-4947.2008.96
|View full text |Cite
|
Sign up to set email alerts
|

Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism

Abstract: BACKGROUND AND OBJECTIVESBecause subclinical thyroid dysfunction may be a risk factor for cardiovascular disease, we evaluated the atherosclerosis tendency in subclinical hypothyroid (SCH) patients.PATIENTS AND METHODSFifty-three subclinical hypothyroid patients (serum thyrotropin [TSH] concentrations >4.12 mU/L) were compared with a control group of 50 euthyroid subjects whose age, sex and body mass indices were similar to the patient group. We tested whether serum TSH concentrations were correlated with plas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
17
2
1

Year Published

2010
2010
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(25 citation statements)
references
References 44 publications
(65 reference statements)
5
17
2
1
Order By: Relevance
“…L-thyroxine substitution brought some improvement in atherosclerosis indexes; however, the de-crease was only statistically significant in overt hypothyroidism group in LDL-C/HDL-C ratio. Some authors reported a similarly beneficial influence of hormone therapy on LDL-C/HDL-C ratio [17], but others failed to show such relations [18]. As for atheroprotective HDL particles, their concentration was lower in both hypothyroidism groups vs. controls in our study.…”
Section: Discussioncontrasting
confidence: 54%
“…L-thyroxine substitution brought some improvement in atherosclerosis indexes; however, the de-crease was only statistically significant in overt hypothyroidism group in LDL-C/HDL-C ratio. Some authors reported a similarly beneficial influence of hormone therapy on LDL-C/HDL-C ratio [17], but others failed to show such relations [18]. As for atheroprotective HDL particles, their concentration was lower in both hypothyroidism groups vs. controls in our study.…”
Section: Discussioncontrasting
confidence: 54%
“…The HepG2 cells stimulated by different concentrations of bTSH (0, 1, and 4 M) were homogenized with a loose-fi tting Tefl on pestle in 4 vol of 3 mM TrisHCl buffer (pH 7.4) containing 0.25 M sucrose, 0.1 mM EDTA, and Subclinical hypothyroidism is a type of thyroid function abnormality; its characteristics are elevated serum thyroidstimulating hormone (TSH) and normal serum thyroid hormone levels, as well as an increased serum cholesterol level ( 10 ). Our study and other clinical studies have addressed a positive correlation between the high serum TSH and increased cholesterol levels ( 11,12 ). Additionally, our laboratory data have shown that the TSH receptor (TSHR) was expressed in hepatocytes and the TSH could enhance the expression of HMGCR by activating the cAMP/PKA pathway, leading to an elevated cholesterol level via the TSHR in the hepatocytes ( 13,14 ).…”
Section: Hepatocellular Microsome Hmgcr Activity Assaymentioning
confidence: 96%
“…Several clinical studies in recent years addressed this issue and showed a correlation in hypothyroidism between high serum cholesterol and high TSH levels, the latter being usually used as an indication of the severity of the hypothyroidism. [5][6][7] In these studies, however, it was impossible to delineate a direct role of TSH as abnormal TH level (usually deficiency) was usually a coexisting factor. Thus, a molecular mechanism by which TSH might affect cholesterol level has never been established.…”
mentioning
confidence: 99%